SCHEMBL6741516

SCHEMBL6741516

CC(C)(C)c1ccc([S+](c2ccc(C(C)(C)C)cc2)c2ccc(C(C)(C)C)cc2)cc1.O=S(=O)([O-])c1ccc(OS(=O)(=O)c2ccccc2)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.50
HSD17B3 P37058 1/20 0.50
ALDH1A1 P00352 7/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RECQL P46063 2/20 0.39
MAPT P10636 2/20 0.39
ESR1 P03372 1/20 0.38
GAA P10253 1/20 0.38
ESR2 Q92731 1/20 0.38
ENPP1 P22413 1/20 0.37
KEAP1 Q14145 2/20 0.35
NFE2L2 Q16236 2/20 0.35
LMNA P02545 3/20 0.34
HTT P42858 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PSD A5PKW4 1/20 0.34
ALPL P05186 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6745171 0.94 HSD11B1 (0.52) HSD11B1HSD17B3ALDH1A1MEN1KMT2A
SCHEMBL6743183 0.93 HSD11B1 (0.48) HSD11B1HSD17B3ALDH1A1MEN1KMT2A
SCHEMBL6744094 0.86 HSD11B1 (0.50) HSD11B1HSD17B3ALDH1A1MEN1KMT2A
SCHEMBL6743671 0.86 KMT2A (0.51) ALDH1A1MEN1KMT2AMAPTESR1
SCHEMBL6740051 0.85 KMT2A (0.53) HSD11B1HSD17B3ALDH1A1MEN1KMT2A
SCHEMBL6742531 0.84 KMT2A (0.52) ALDH1A1MEN1KMT2AMAPTESR1
SCHEMBL7120580 0.83 HSD11B1 (0.49) HSD11B1HSD17B3ALDH1A1MEN1KMT2A
SCHEMBL6741520 0.81 HSD11B1 (0.52) HSD11B1HSD17B3ALDH1A1MEN1KMT2A
SCHEMBL6746238 0.81 HSD11B1 (0.50) HSD11B1HSD17B3ALDH1A1MEN1KMT2A
SCHEMBL6745165 0.81 KMT2A (0.44) HSD11B1HSD17B3ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6692893-B2 ONIUM SALTS OF ARYLSULFONYLOXYNAPHTHALENESULFONATE ANIONS WITH IODONIUM OR SULFONIUM CATIONS; USE IN DEEP ULTRAVIOLET LITHOGRAPHY SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-02-17 US disclosed
US-20020076643-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020076643-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process PNN, PI4K2B, PI4K2A HSD11B1 2902/4885HSD17B3 3207/4885ALDH1A1 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.